These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8782860)

  • 1. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
    Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
    Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.
    Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN
    Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel medications for drug addiction. The legacy of an African shrub.
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of antiaddictive actions of ibogaine.
    Glick SD; Maisonneuve IS
    Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine-like effects of noribogaine in rats.
    Glick SD; Pearl SM; Cai J; Maisonneuve IM
    Brain Res; 1996 Mar; 713(1-2):294-7. PubMed ID: 8725004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.
    Maisonneuve IM; Glick SD
    Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
    Maisonneuve IM; Glick SD
    Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.
    Wei D; Maisonneuve IM; Kuehne ME; Glick SD
    Brain Res; 1998 Aug; 800(2):260-8. PubMed ID: 9685673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
    Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
    Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons.
    French ED; Dillon K; Ali SF
    Life Sci; 1996; 59(12):PL199-205. PubMed ID: 8809219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Alkaloids Chem Biol; 2001; 56():39-53. PubMed ID: 11705115
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of Antiaddictive Actions of Ibogaine
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 1998 May; 844(1):214-226. PubMed ID: 29090809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18-MC reduces methamphetamine and nicotine self-administration in rats.
    Glick SD; Maisonneuve IM; Dickinson HA
    Neuroreport; 2000 Jun; 11(9):2013-5. PubMed ID: 10884062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.
    Glick SD; Ramirez RL; Livi JM; Maisonneuve IM
    Eur J Pharmacol; 2006 May; 537(1-3):94-8. PubMed ID: 16626688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference.
    McCallum SE; Glick SD
    Neurosci Lett; 2009 Jul; 458(2):57-9. PubMed ID: 19442876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.